{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:52:45Z","timestamp":1787223165338,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ijpharm.2004.03.016","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T10:35:29Z","timestamp":1084530929000},"page":"353-360","source":"Crossref","is-referenced-by-count":55,"title":["Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate"],"prefix":"10.1016","volume":"278","author":[{"given":"Davide","family":"Guggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Langoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2004.03.016_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00365-8","article-title":"Chitosan and its derivatives: potential excipients for peroral peptide delivery systems","volume":"194","author":"Bernkop-Schn\u00fcrch","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2003.10.005","article-title":"Thiolated chitosans: development and in vivo evaluation of a mucoadhesive permeation enhancing oral drug delivery system","volume":"94","author":"Bernkop-Schn\u00fcrch","year":"2003","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-5173(96)04847-8","article-title":"Evaluation of the biological properties of soluble chitosan and chitosan microspheres","volume":"148","author":"Carreno-Gomez","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(99)00235-7","article-title":"Poly l-glutamic acid derivatives as vectors for gene therapy","volume":"65","author":"Dekie","year":"2000","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB5","unstructured":"Ferruti, P., Knobloch, S., Ranucci, E., Gianasi, E., Duncan, R. 1997. A novel chemical modification of poly-l-lysine reducing toxicity while preserving cationic properties. In: Proc. Int. Symp. Control. Rel. Bioact. Mater."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.7123245","article-title":"Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for detection of DNA replication","volume":"218","author":"Gratzner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1023\/B:PHAM.0000008047.82334.7d","article-title":"In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix","volume":"20","author":"Guggi","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-3659(03)00299-2","article-title":"Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin","volume":"92","author":"Guggi","year":"2003","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0939-6411(02)00162-5","article-title":"In vitro evaluation of the viscoelastic behavior of chitosan\u2014thioglycolic acid conjugates","volume":"55","author":"Hornof","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0142-9612(96)81421-9","article-title":"In vitro biocompatibility of bioresorbable polymers: poly(l, dl-lactide) and poly(l-lactide-co-glycolide)","volume":"17","author":"Ignatius","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Illum","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1023\/A:1012106907708","article-title":"N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2)","volume":"14","author":"Kotze","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P","article-title":"Use of chitosan as a biomaterial: studies on its safety and hemostatic potential","volume":"34","author":"Rao","year":"1997","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0939-6411(03)00157-7","article-title":"Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation","volume":"57","author":"Roldo","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00839070","article-title":"Methods for evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use. 1. Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation of in vitro cytotoxicity","volume":"1","author":"Sgouras","year":"1990","journal-title":"J. Mater. Med."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0167-4838(92)90257-E","article-title":"Interactions of polycations with cell-surface negative charges of epithelial cells","volume":"1120","author":"Singh","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0169-409X(00)00120-4","article-title":"Mucoadhesive nanoparticulate systems for peptide drug delivery","volume":"47","author":"Takeuchi","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2004.03.016_BIB19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(00)00590-1","article-title":"Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups","volume":"211","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T09:55:53Z","timestamp":1549706153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0378517304002030"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2004.03.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}